ABOS vs NIO · $73.3M cap vs rev $12.51B
Acumen Pharmaceuticals Inc (ABOS) versus Nio Inc Class A ADR (NIO) — a side-by-side from cached financials, not a winner call.
Acumen Pharmaceuticals Inc (ABOS) is a biotechnology company listed on US.
Nio Inc Class A ADR (NIO) is a auto manufacturers company listed on US.
ABOS does not have a complete income-statement cache yet.
Latest reported NIO revenue for 2025-12-31 was $12.51B. Net income was -$2.14B. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. NIO currently screens at market cap $7.61B.
ABOS currently screens at market cap $73.3M. NIO currently screens at market cap $7.61B.
Not investment advice. Open the ABOS and NIO stock pages for the full models.
Not investment advice.